COMPOUND | CATEGORY | CAT. No. | CAS. No. | ACTIONS |
---|---|---|---|---|
|
Impurity | CS-O-32359 | 183322-17-0 | |
|
Impurity | CS-O-30852 | 54060-30-9 | |
4-(3-((6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-37085 | Not Available | |
6,6',7,7'-tetrakis(2-methoxyethoxy)-4H-[3,4'-biquinazolin]-4... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-37086 | Not Available | |
6,7-bis(2-methoxyethoxy)-N-(3-vinylphenyl)quinazolin-4-amine R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-37084 | 1058132-82-3 | |
6-O-Desmethoxyethyl-6-O-chloroethyl Erlotinib Hydrochloride R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-T-52184 | 183320-04-9 | |
|
Impurity | CS-T-89073 | 183365-34-6 | |
|
Impurity | CS-O-36198 | Not Available | |
7-O-Desmethoxy-7-O-chloroethyl Erlotinib Hydrochloride R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-T-52185 | 183320-19-6 | |
|
Impurity | CS-T-16312 | 183320-15-2 | |
|
Impurity | CS-T-52743 | 183320-12-9 | |
|
Impurity | CS-O-33313 | 1278586-80-3 | |
|
Impurity | CS-ED-41702 | 1417161-98-8(free base) | |
|
Impurity | CS-EO-00069 | 1710372-46-5 | |
|
Impurity | CS-P-07859 | 950596-59-5 | |
|
Impurity | CS-P-07860 | 236750-65-5 | |
|
Impurity | CS-P-07861 | 236750-62-2 | |
|
Impurity | CS-P-07862 | 183322-16-9 | |
|
Impurity | CS-P-07864 | 1312937-41-9 | |
|
Impurity | CS-EO-03533 | 2055841-66-0 | |
|
Impurity | CS-O-32530 | 938185-06-9 | |
|
Impurity | CS-EO-03534 | 1354727-63-1 (Freebase) | |
|
Impurity | CS-P-07857 | 179688-26-7 | |
|
Impurity | CS-AQ-00190 | 13794-72-4 | |
|
Impurity | CS-P-07856 | 1624294-38-7 | |
|
Impurity | CS-AQ-00201 | 183320-29-8 | |
Erlotinib impurity, 6-(2-chloroethoxy)-7-(2-methoxyethoxy) R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-P-07855 | 183321-83-7 | |
Erlotinib impurity, 6-(2-methoxyethoxy)-7-(2-chloroethoxy) R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-P-07854 | 183321-85-9 | |
Erlotinib impurity, 6,7-bis(2-chloroethoxy) R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-P-07853 | 183321-82-6 | |
|
Impurity | CS-O-46248 | 299912-59-7 | |
|
Impurity | CS-P-08699 | 299912-60-0 | |
|
Impurity | CS-EO-03535 | 299912-60-0 (Freebase) | |
|
Impurity | CS-O-16945 | Not Available | |
|
Impurity | CS-T-95872 | Not Available | |
N-(3-Desethynylphenyl)-N-(3-(1-chlorovinyl)phenyl) Erlotinib R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-33361 | 2204518-92-1 |